Cargando…

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice

BACKGROUND: Interleukin- (IL-) 22 is considered a proinflammatory cytokine. Recent evidence has demonstrated that it plays a role in cardiovascular diseases. In the recent study, we investigate whether IL-22 is involved in cardiac hypertrophy. METHODS: Angiotensin II was used to build hypertrophy mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Jing, Liu, Ling, Ji, Qingwei, Huang, Ying, Shi, Ying, Shi, Lei, Liu, Jianfang, Wang, Menglong, Xu, Yao, Jiang, Huimin, Wang, Zhen, Lin, Yingzhong, Wan, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735629/ https://www.ncbi.nlm.nih.gov/pubmed/29358851 http://dx.doi.org/10.1155/2017/5635929

Ejemplares similares

Erratum to “Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice”
por: Ye, Jing, et al.
Publicado: (2018)

Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II–Treated Mice
por: Ye, Jing, et al.
Publicado: (2017)

Increased Interleukin-11 Levels Are Correlated with Cardiac Events in Patients with Chronic Heart Failure
por: Ye, Jing, et al.
Publicado: (2019)

Interleukin-12p35 Knock Out Aggravates Doxorubicin-Induced Cardiac Injury and Dysfunction by Aggravating the Inflammatory Response, Oxidative Stress, Apoptosis and Autophagy in Mice
por: Ye, Jing, et al.
Publicado: (2018)

Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice
por: Ye, Jing, et al.
Publicado: (2020)

Interleukin-12p35 deficiency enhances mitochondrial dysfunction and aggravates cardiac remodeling in aging mice
por: Ye, Jing, et al.
Publicado: (2020)

TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
por: Wang, Zhen, et al.
Publicado: (2018)

Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Corrigendum to “Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice”
por: Zhang, Jianwei, et al.
Publicado: (2022)

Corrigendum to “TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice” [EBioMedicine (2018) 54–62]
por: Wang, Zhen, et al.
Publicado: (2018)

Roles and Mechanisms of Interleukin-12 Family Members in Cardiovascular Diseases: Opportunities and Challenges
por: Ye, Jing, et al.
Publicado: (2020)

The expression of interleukin-25 increases in human coronary artery disease and is associated with the severity of coronary stenosis
por: Xu, Yao, et al.
Publicado: (2020)

The Anti-Inflammatory Mediator 17(R)-Resolvin D1 Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Wang, Menglong, et al.
Publicado: (2023)

Inhibition of TRPA1 Attenuates Doxorubicin-Induced Acute Cardiotoxicity by Suppressing Oxidative Stress, the Inflammatory Response, and Endoplasmic Reticulum Stress
por: Wang, Zhen, et al.
Publicado: (2018)

Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice
por: Huang, Ying, et al.
Publicado: (2019)

Novel EGFR inhibitors attenuate cardiac hypertrophy induced by angiotensin II
por: Peng, Kesong, et al.
Publicado: (2016)

Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients
por: Ye, Jing, et al.
Publicado: (2018)

Interleukin-22 is elevated in the atrium and plasma of patients with atrial fibrillation and increases collagen synthesis in transforming growth factor-β1-treated cardiac fibroblasts via the JNK pathway
por: Wu, Yongxin, et al.
Publicado: (2020)

The clinical potential of IL-12/IL-35 in treating chemotherapy drug-induced cardiac injury – Authors' reply
por: Ye, Jing, et al.
Publicado: (2018)

Interleukin 22 attenuated angiotensin II induced acute lung injury through inhibiting the apoptosis of pulmonary microvascular endothelial cells
por: Wu, Zhiyong, et al.
Publicado: (2017)

Impact of ethyl pyruvate on Adriamycin-induced cardiomyopathy in rats
por: Liu, Menglin, et al.
Publicado: (2016)

Association of the interleukin-22 genetic polymorphisms with ulcerative colitis
por: Chi, Hong Gang, et al.
Publicado: (2014)

Anti-Interleukin-16 Neutralizing Antibody Treatment Alleviates Sepsis-Induced Cardiac Injury and Dysfunction via the Nuclear Factor Erythroid-2 Related Factor 2 Pathway in Mice
por: Zhang, Jianwei, et al.
Publicado: (2021)

Molecular mechanism of antibody neutralization of coxsackievirus A16
por: Zhang, Chao, et al.
Publicado: (2022)

I-κB Kinase-ε Deficiency Attenuates the Development of Angiotensin II-Induced Myocardial Hypertrophy in Mice
por: Cao, Yide, et al.
Publicado: (2021)

Resolvin D1 Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Inflammation, Oxidative and Endoplasmic Reticulum Stress
por: Wang, Menglong, et al.
Publicado: (2022)

The Expression of IL-12 Family Members in Patients with Hypertension and Its Association with the Occurrence of Carotid Atherosclerosis
por: Ye, Jing, et al.
Publicado: (2020)

Effects of circulating levels of Th17 cells on the outcomes of acute Stanford B aortic dissection patients after thoracic endovascular aortic repair: A 36-month follow-up study a cohort study
por: Liu, Hongtao, et al.
Publicado: (2019)

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
por: Liu, Ling, et al.
Publicado: (2016)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

CD38 promotes angiotensin II‐induced cardiac hypertrophy
por: Guan, Xiao‐Hui, et al.
Publicado: (2017)

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab
por: Okragly, Angela J., et al.
Publicado: (2023)

Decreased Plasma IL-35 Levels Are Related to the Left Ventricular Ejection Fraction in Coronary Artery Diseases
por: Lin, Yingzhong, et al.
Publicado: (2012)

Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
por: Du, Fawang, et al.
Publicado: (2021)

ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease
por: Wang, Zhen, et al.
Publicado: (2019)

The TRPA1 Channel in the Cardiovascular System: Promising Features and Challenges
por: Wang, Zhen, et al.
Publicado: (2019)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Angiotensin-(1-7) attenuates hypertension and cardiac hypertrophy via modulation of nitric oxide and neurotransmitter levels in the paraventricular nucleus in salt-sensitive hypertensive rats
por: Liang, Bin, et al.
Publicado: (2018)

Paeonol improves angiotensin II-induced cardiac hypertrophy by suppressing ferroptosis
por: Liu, Canzhang, et al.
Publicado: (2023)

Interleukin-22 signaling attenuates necrotizing enterocolitis by promoting epithelial cell regeneration
por: Mihi, Belgacem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4ngsfdt42a3j93aus2kebjqsus